Friday, April 18, 2025

12:00PM – 1:00PM ET

Please note this Clinical Conversation program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.

PRESENTING FACULTY

	Reshma L. Mahtani, DO Chief of Breast Medical Oncology Miami Cancer Institute Baptist Health South Florida Miami, FL
	Savitri Krishnamurthy, MD Department of Pathology The University of Texas, MD Anderson Cancer Center Houston, TX

PROGRAM OVERVIEW

This interactive, case-based educational program is designed for oncologists and pathologists. Expert faculty will discuss key topics surrounding HER2 testing in metastatic breast cancer, using cases to illustrate and reinforce core principles and knowledge. Upon completion of the program, learners from the target audience will be better able to apply evidence-based guidelines and recommendations toward optimizing HER2 testing, interpretation and reporting. Further, they will be better able to determine treatment pathways for metastatic breast cancers, based on HER2 testing outcomes.

TARGET AUDIENCE

This educational activity is intended for oncologists and pathologists.

LEARNING OBJECTIVE

Upon the completion of this program, attendees should be able to:

• Apply considerations for HER2-low testing, including for sample preparation, testing strategy, interpretation of staining, and reporting test outcomes
• Summarize the latest clinical practice guideline recommendations for HER2-low testing and reporting per the ASCO-CAP and NCCN guidelines, as well as the importance of multidisciplinary discussion in treatment planning
• Describe the clinical trial data for trastuzumab deruxtecan in treating HER2-low metastatic breast cancer

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com